Chronic Kidney Disease and Cerebrovascular Disease

Dearbhla Kelly(John Radcliffe Hospital), Manish M. Sood, Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Gregory Y.H. Lip(University of Liverpool), Patrick B. Mark(University of Glasgow), Michael Cheung, Holger Reinecke(University Hospital Münster), Charles A. Herzog, Mark J. Sarnak(Tufts Medical Center), Wolfram Doehner, Christopher X. Wong(Royal Adelaide Hospital), Kirsten L. Johansen, Zanfina Ademi(Monash University)

Stroke

June 3, 2021

10.1161/strokeaha.120.029680

Cited by 142

Related Papers

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

|The Lancet|2018|5k

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

|Journal of the American College of Cardiology|2020|2.9k

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

|The Lancet|2014|2.7k

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012

|European Journal of Heart Failure|2012|2.6k

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

|European Heart Journal|2016|2.5k